Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 13.91
- Piotroski Score 3.00
- Grade N/A
- Symbol (ERES)
- Company East Resources Acquisition Company
- Price $10.85
- Changes Percentage (8.18%)
- Change $0.82
- Day Low $10.42
- Day High $11.27
- Year High $11.27
East Resources Acquisition Company does not have significant operations. The company focuses on effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of energy in North America. The company was incorporated in 2020 and is headquartered in Boca Raton, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/30/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.23
- Trailing P/E Ratio -47.173913043478
- Forward P/E Ratio -47.173913043478
- P/E Growth -47.173913043478
- Net Income $9.52 M
Income Statement
Quarterly
Annual
Latest News of ERES
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Money Market Interest Rates Today: November 18, 2024 -- Earn Up To 5.00%
Money market rates fluctuate, with the current average at 0.57% and the best rate at 5.00%. These accounts offer higher interest than savings accounts but may have higher minimum balances and transact...
By Forbes | 1 hour ago -
Everest Medicines (SEHK:1952) Eyes Growth with EVER001 Launch and AI Investments Despite Profitability Concerns
Everest Medicines (SEHK:1952) anticipates a 37.2% annual revenue growth driven by EVER001 introduction. Challenges include unprofitability and cost management issues....
By Yahoo! Finance | 11 hours ago -
'Self-interest is winning': Prince William's low blow to sick...
Prince William's recent interview reveals his vision for a more empathetic, impactful monarchy, contrasting with his father, King Charles. The royal family's internal struggles, including Prince Andre...
By New York Post | 22 hours ago
